Cemtrex IncCETX
Price$2.03

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $71.2M+6.4% YoYTTM through 30 Jun 2026
Net Income -$27.5MTTM through 30 Jun 2026
Free Cash Flow -$9.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin38.0%
EBITDA Margin-7.3%
Operating Margin-12.2%
Net Margin-38.6%

Returns

2.6%ROE
1.3%ROA

Balance Sheet Health

Debt / Equity0.51x
Current Ratio1.57x
Net Debt$13M
Cash & Equivalents$8M

Quality Metrics

Altman Z-Score-1.52
Piotroski F-Score3 / 9
FCF Margin-13.5%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $76.5M
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $-212.34

Dividend

No dividend

Capital Allocation

R&D Spend$1.8M
Capex Intensity2.1%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.